Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q3 2025 (September 30)2holders −1
0new positions
1sold out
$1.31avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.0M) and Bank of New York Mellon Corp ($391K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $12.5M |
All 13F filers, Q2 2025 → Q3 2025: 100,000 shares bought and 379,373 shares sold, net −279,373 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 1,500,000 | $2.0M |
| Bank of New York Mellon Corp | 0.00% | Add +50.0% | 300,000 | $391K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.